Michelle Williamson, MD

Albert Einstein College of Medicine and Montefiore Medical Center · 2 sessions at 1 meeting · 1 upcoming

Topics

Drug Interactions & Safety (2)Opioid Use Disorder (2)Long-Acting InjectablesMedical Comorbidity & C-L Psychiatry

Sessions

AAAP 37th Annual Meeting and Scientific Symposium

November 12–15, 2026 · Memphis, TN · Full program

  • SessionAn ICD for Harm Reduction: Methadone-Associated Torsades de Pointes in a Patient With Opioid Use Disorder

    November 13, 2026, 10:40–12:10

    Case of a man with opioid use disorder who developed torsades de pointes on methadone and other QT-prolonging exposures. Discusses withdrawal management, methadone retitration, and the decision to place a subcutaneous ICD as a harm reduction measure.

    Drug Interactions & SafetyOpioid Use DisorderMedical Comorbidity & C-L Psychiatry

  • PosterFrom Methadone 200 mg/day to Brixadi: Successful Inpatient Transition Using Low-Dose Buprenorphine Induction for Persistent QTc Prolongation

    November 15, 2026, 08:00–09:30

    Case of transitioning from high-dose methadone to extended-release buprenorphine due to QTc prolongation.

    Drug Interactions & SafetyLong-Acting InjectablesOpioid Use Disorder

Speaker listings come from official conference programs and may change — confirm on each meeting's site. Spot an error? Names printed differently on different programs are merged conservatively.

Is this you? Add your photo

Send us a headshot and we'll show it on this page and next to your sessions. Every submission is reviewed by a person before it goes live; we never share your email.

Browse the directory

By date

By specialty

By location

By type

By audience

Speakers & topics

Recurring meetings